
UTHR
United Therapeutics CorporationNASDAQHealthcare$564.81-0.96%ClosedMarket Cap: $24.75B
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
4
Sales
39
Buy/Sell Ratio
0.10
Total Bought
$0.00
Total Sold
$35.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 1,629 | $566.66 | 48,175 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 1,403 | $567.55 | 46,772 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 1,115 | $564.55 | 50,347 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 774 | $562.34 | 51,833 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 690 | $568.79 | 46,082 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 543 | $565.66 | 49,804 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 514 | $560.30 | 52,958 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 371 | $563.58 | 51,462 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 351 | $561.69 | 52,607 |
| Thu Apr 02 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 8,300 | $146.03 | 53,472 |
| Tue Mar 31 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 1,790 | $588.33 | 46,197 |
| Tue Mar 31 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 1,734 | $589.18 | 44,463 |
| Tue Mar 31 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 1,346 | $587.34 | 47,987 |
| Tue Mar 31 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 1,068 | $590.32 | 43,395 |
| Tue Mar 31 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 602 | $591.24 | 42,793 |